Recent studies have demonstrated that hepatic de novo lipogenesis is increased in NAFLD as a result of overexpression of SREBP-1c, which is an important transcription factor that up-regulates genes such as FAS, and this promotes fatty acid and TG syntheses [21]. This evidence concerns the gene FAS and metabolic dysfunction-associated steatotic liver disease.